Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency

Ivano Di Meo, Cristina Colombelli, Balaji Srinivasan, Marianne De Villiers, Jeffrey Hamada, Suh Y. Jeong, Rachel Fox, Randall L. Woltjer, Pieter G. Tepper, Liza L. Lahaye, Emanuela Rizzetto, Clara H. Harrs, Theo De Boer, Marianne Van Der Zwaag, Branko Jenko, Alen Čusak, Jerca Pahor, Gregor Kosec, Nicola A. Grzeschik, Susan J. Hayflick & 2 others Valeria Tiranti, Ody C.M. Sibon

Research output: Research - peer-reviewArticle

Abstract

Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration for which no treatment is available. One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step in the pathway. Here we describe the synthesis, characteristics and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4′-phosphopantetheine as a possible treatment for neurodegeneration associated with pantothenate kinase deficiency.

LanguageEnglish (US)
Article number11260
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Coenzyme A
Phenotype
Serum
pantothenate kinase
4'-phosphopantetheine
Pantothenate Kinase-Associated Neurodegeneration
Pantothenic Acid
Acetyl Coenzyme A
Mutation
Genes
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Di Meo, I., Colombelli, C., Srinivasan, B., De Villiers, M., Hamada, J., Jeong, S. Y., ... Sibon, O. C. M. (2017). Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency. Scientific Reports, 7(1), [11260]. DOI: 10.1038/s41598-017-11564-8

Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency. / Di Meo, Ivano; Colombelli, Cristina; Srinivasan, Balaji; De Villiers, Marianne; Hamada, Jeffrey; Jeong, Suh Y.; Fox, Rachel; Woltjer, Randall L.; Tepper, Pieter G.; Lahaye, Liza L.; Rizzetto, Emanuela; Harrs, Clara H.; De Boer, Theo; Van Der Zwaag, Marianne; Jenko, Branko; Čusak, Alen; Pahor, Jerca; Kosec, Gregor; Grzeschik, Nicola A.; Hayflick, Susan J.; Tiranti, Valeria; Sibon, Ody C.M.

In: Scientific Reports, Vol. 7, No. 1, 11260, 01.12.2017.

Research output: Research - peer-reviewArticle

Di Meo, I, Colombelli, C, Srinivasan, B, De Villiers, M, Hamada, J, Jeong, SY, Fox, R, Woltjer, RL, Tepper, PG, Lahaye, LL, Rizzetto, E, Harrs, CH, De Boer, T, Van Der Zwaag, M, Jenko, B, Čusak, A, Pahor, J, Kosec, G, Grzeschik, NA, Hayflick, SJ, Tiranti, V & Sibon, OCM 2017, 'Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency' Scientific Reports, vol 7, no. 1, 11260. DOI: 10.1038/s41598-017-11564-8
Di Meo I, Colombelli C, Srinivasan B, De Villiers M, Hamada J, Jeong SY et al. Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency. Scientific Reports. 2017 Dec 1;7(1). 11260. Available from, DOI: 10.1038/s41598-017-11564-8
Di Meo, Ivano ; Colombelli, Cristina ; Srinivasan, Balaji ; De Villiers, Marianne ; Hamada, Jeffrey ; Jeong, Suh Y. ; Fox, Rachel ; Woltjer, Randall L. ; Tepper, Pieter G. ; Lahaye, Liza L. ; Rizzetto, Emanuela ; Harrs, Clara H. ; De Boer, Theo ; Van Der Zwaag, Marianne ; Jenko, Branko ; Čusak, Alen ; Pahor, Jerca ; Kosec, Gregor ; Grzeschik, Nicola A. ; Hayflick, Susan J. ; Tiranti, Valeria ; Sibon, Ody C.M./ Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{eaefb25b59864e339958bc092dc7b55f,
title = "Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency",
abstract = "Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration for which no treatment is available. One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step in the pathway. Here we describe the synthesis, characteristics and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4′-phosphopantetheine as a possible treatment for neurodegeneration associated with pantothenate kinase deficiency.",
author = "{Di Meo}, Ivano and Cristina Colombelli and Balaji Srinivasan and {De Villiers}, Marianne and Jeffrey Hamada and Jeong, {Suh Y.} and Rachel Fox and Woltjer, {Randall L.} and Tepper, {Pieter G.} and Lahaye, {Liza L.} and Emanuela Rizzetto and Harrs, {Clara H.} and {De Boer}, Theo and {Van Der Zwaag}, Marianne and Branko Jenko and Alen Čusak and Jerca Pahor and Gregor Kosec and Grzeschik, {Nicola A.} and Hayflick, {Susan J.} and Valeria Tiranti and Sibon, {Ody C.M.}",
year = "2017",
month = "12",
doi = "10.1038/s41598-017-11564-8",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Acetyl-4′-phosphopantetheine is stable in serum and prevents phenotypes induced by pantothenate kinase deficiency

AU - Di Meo,Ivano

AU - Colombelli,Cristina

AU - Srinivasan,Balaji

AU - De Villiers,Marianne

AU - Hamada,Jeffrey

AU - Jeong,Suh Y.

AU - Fox,Rachel

AU - Woltjer,Randall L.

AU - Tepper,Pieter G.

AU - Lahaye,Liza L.

AU - Rizzetto,Emanuela

AU - Harrs,Clara H.

AU - De Boer,Theo

AU - Van Der Zwaag,Marianne

AU - Jenko,Branko

AU - Čusak,Alen

AU - Pahor,Jerca

AU - Kosec,Gregor

AU - Grzeschik,Nicola A.

AU - Hayflick,Susan J.

AU - Tiranti,Valeria

AU - Sibon,Ody C.M.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration for which no treatment is available. One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step in the pathway. Here we describe the synthesis, characteristics and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4′-phosphopantetheine as a possible treatment for neurodegeneration associated with pantothenate kinase deficiency.

AB - Coenzyme A is an essential metabolite known for its central role in over one hundred cellular metabolic reactions. In cells, Coenzyme A is synthesized de novo in five enzymatic steps with vitamin B5 as the starting metabolite, phosphorylated by pantothenate kinase. Mutations in the pantothenate kinase 2 gene cause a severe form of neurodegeneration for which no treatment is available. One therapeutic strategy is to generate Coenzyme A precursors downstream of the defective step in the pathway. Here we describe the synthesis, characteristics and in vivo rescue potential of the acetyl-Coenzyme A precursor S-acetyl-4′-phosphopantetheine as a possible treatment for neurodegeneration associated with pantothenate kinase deficiency.

UR - http://www.scopus.com/inward/record.url?scp=85029305251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029305251&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-11564-8

DO - 10.1038/s41598-017-11564-8

M3 - Article

VL - 7

JO - Scientific Reports

T2 - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 11260

ER -